1. Current global market of Synthetic Biology:

 

Synthetic biology is a rapidly emerging area of biological research which combines both science and engineering. Considering its growth rate, it is believed to dominate the global market in the future. Hot trends of the global synthetic biology market are Computer-aided Technology, Cell-Free Technology, Food Technology and Bio monitoring.

 

Global Synthetic Biology market size exceeded USD 11 billion in 2018 and is continuously growing. Its strong influence in major industries including agriculture, industrial chemicals, and health care will lead to the industry’s growth.

​

2. Comparison of Synthetic Biology by Region:

 

In 2018, North America was the most important region, with 41% to 43% of the total market demand, while the synthetic biology industry in the Asia Pacific region accounted for over 25% market share. The European synthetic biology market is expected to register the fastest CAGR by 2025 of 25%.

​

The synthetic biology market in the Asia Pacific region is estimated to grow at the highest CAGR during 2020 according to a report by MarketsAndMarkets, mainly due to factors such as the growing collaborations within the field of synthetic biology, growing partnerships among the Chinese market industries, and investments in Asia Pacific countries for research.

​

3. Investment Trends in Synthetic Biology:

​

Increasing investments in R&D activities supported by the government agencies is providing a positive outlook for businesses across the global market. As per National Science Foundation, U.S. invested around USD 820 million from 2008-2014 and is the largest investor in the synthetic biology market. Also, UK invested over USD 330 million from 2008-2016.

 

As a result of increasing government investments, many biotechnological and pharmaceutical companies are more focusing on research & development activity which has helped in development of the synthetic biology industry. The reasons of the wide acceptability and investments in this industry are optimized production process, improved access to renewable energy and reduced carbon footprints.

​

Synthetic biology has also piqued the interest of various tech titans like Eric Schmidt (Google), Peter Thiel (PayPal), Vinod Khosla (Sun Microsystems), Marc Andreessen (Netscape), Jerry Yang (Yahoo!), Bill Gates (Microsoft), Bryan Johnson (Venmo), and Max Levchin (PayPal), garnering more than $12.3B in the last 10 years.

​

​

​

4. Top Synthetic Biotech Companies:

​

There are 488 synthetic biology companies in the world, with many startups still coming up.

Some of the top SynBio companies are - 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

https://www.genengnews.com/a-lists/top-10-synthetic-biology-companies/

​

​

​

​